Disc Medicine management said earlier this month that its application seeking approval for Bitopertin has officially been ...

WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...

MELVILLE, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical ...

Findings from an interim analysis showed CELZ-201-DDT statistically significantly reduced pain and improved mobility in patients with chronic lower back pain. The Food and Drug Administration (FDA) ...

Harmonix has officially unveiled the track list for Rock Band 2. Besides being packed with rock gods like AC/DC exclusively, GNR’s Chinese Democracy’s official debut, Alice in Chains and Rage Against ...

Disc Medicine recently announced the submission of a New Drug Application for bitopertin for erythropoietic protoporphyria, accompanied by the receipt of the FDA Commissioner’s National Priority ...

Ridewell Suspensions has released a new series of short track axles that can be configured with automatic tire inflation systems. This shorter series axle comes with a wall thickness of .75 inches and ...

Cambridge, MA – August 13, 2009-- Harmonix, the leading developer of music-based games, and MTV Games, a part of Viacom’s MTV Networks, (NYSE: VIA, VIA.B), along with distribution partner Electronic ...

A new track by Lena Raine was released as a music disc item in Minecraft version 1.18. 'Otherside' is an upbeat track that is great for bumping from a jukebox as players go about their tasks. Like ...

BioRestorative Therapies, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its BRTX-100 program for treating chronic lumbar disc disease (cLDD).

When it comes to treating back pain, particularly chronic lumbar disc disease (cLDD), the industry is falling short. Sure there's surgery, but that’s an invasive option that isn't always a success.